International Clinical Trial: Efficacy and Safety of Cofrogliptin versus Metformin Dose Escalation in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin and Comorbid Non-Alcoholic Fatty Liver Disease

Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127160) titled 'Efficacy and Safety of Cofrogliptin versus Metformin Dose Escalation in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin and Comorbid Non-Alcoholic Fatty Liver Disease' on June 25.

Study Type: Interventional study

Study Design: Non randomized control

Primary Sponsor: Xi'an Jiaotong University Second Affiliated Hospital

Condition: Type 2 diabetes mellitus Nonalcoholic fatty liver disease

Intervention: Control group:Metformin Dose Escalation

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-25

Target Sample Size: Control group:118;Experimental ...